Vector image of black body surrounded by white clouds
Multiple Possible Causes of Long COVID Come into Focus
Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  
Multiple Possible Causes of Long COVID Come into Focus
Multiple Possible Causes of Long COVID Come into Focus

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

Recent studies have lent support for a variety of hypotheses explaining the debilitating symptoms affecting millions of people after SARS-CoV-2 infection.  

B cells
A germinal center inside a lymph node
Slow Vaccine Delivery May Maximize Immune Response
Alejandra Manjarrez | Sep 23, 2022
A vaccine strategy involving formulation changes, an initial escalating dose, and a longer wait for booster immunization results in more-effective antibody production against HIV in rhesus monkeys, a study finds.
stained microscope image of a germinal center inside a lymph node
Booster Is Best in the Same Limb as Initial Vaccine: Mouse Study
Alejandra Manjarrez | May 6, 2022
Compared to mice who got the doses in separate limbs, animals receiving flu shots in the same paw for both a first and second dose had better-trained memory B cells that bound tighter to the vaccine antigen.
COVID-19 vaccine vials
COVID-19 Vaccines Induce Better Long-Term Immunity than Infection
Jennifer Zieba, PhD
For the first time, researchers performed a head-to head longitudinal study comparing the immune response elicited by mRNA and traditional COVID-19 vaccines to primary infections.
Bispecific Antibodies Treat Cancer in Mouse Models
Abby Olena | Mar 5, 2021
A trio of papers shows that specialized antibodies can direct T cells to destroy cells that display portions of mutant cancer-related proteins, as well as T cells that have become cancerous themselves.
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Ashley Yeager | Nov 23, 2020
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
Learn How the Immune System Can Be Trained to Overcome Food Allergies
Retraining the Immune System Cavalry for Food Allergen Peacekeeping Missions
The Scientist Creative Services Team
Explore food allergy immunotherapy for reversing patient symptoms.
Common Cold Coronaviruses Tied to Less Severe COVID-19 Cases
Anthony King | Nov 11, 2020
Outcomes in COVID-19 patients may be better in those recently infected with endemic coronaviruses. 
Cracking Down on Cancer: A Profile of Owen Witte
Diana Kwon | Apr 1, 2020
Through his studies on cancer-causing viruses, the University of California, Los Angeles, professor has helped develop lifesaving treatments.
Peripheral blood mononuclear cells surrounded by red blood cells in circulating blood.
Accelerating Immune Research with Cryopreserved Peripheral Blood Mononuclear Cells
The Scientist Creative Services Team and MilliporeSigma
Commerically-available peripheral blood mononuclear cells offer a well-characterized, accessible, and consistent model for immunology and therapeutic development.
a drop of blood for a newborn's heel is placed on a piece of paper
Gene Therapy Effective for Severe Combined Immunodeficiency
Shawna Williams | Apr 17, 2019
Researchers report they’ve found a way to restore immune function in infants with one form of “bubble boy disease.”
Culprit for Antibody Blockade Identified
Amanda B. Keener | Oct 21, 2016
Type I interferon organizes several immune mechanisms to suppress B cell responses to a chronic viral infection.
istock image 800x560
Can mRNA Vaccine Momentum Propel Tumor Immunotherapies?
Aparna Nathan
A guide to mRNA-based cancer vaccines and where they’re headed next
Enhancing Vaccine Development
Wudan Yan | Jun 1, 2016
Using proteomics methods to inform antigen selection
When the Flu Vax Fails
Jef Akst | Dec 16, 2015
The status of a person’s immune system can predict when a seasonal flu vaccination will not provide sufficient protection, according to a study. 
Enhancing the Efficacy of CAR-T Cell Therapies
The Scientist Creative Services Team in Collaboration with IsoPlexis
Jessica Morris will discuss strategies to improve CAR-T cell targeting, activation, and killing capabilities.
B Cells Can Drive Inflammation in MS
Anna Azvolinsky | Oct 21, 2015
Researchers identify a subset of proinflammatory cytokine-producing B cells that may spark multiple sclerosis-related inflammation.  
Studying Ebola Survivors
Amanda B. Keener | Apr 6, 2015
A scientist jumps at the chance to study the blood of four Ebola survivors to better understand how the immune system responds to the deadly virus. 
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
The Scientist Creative Services Team
Alessandro Sette and Shane Crotty discuss the T cell response to SARS-CoV-2 and the implications for vaccine design and robust immune memory.
cards for a memory game, with pictures of pathogens turned over
Thanks for the Memories
Ruth Williams | Feb 1, 2015
B and T cells may be the memory masters of the immune system, but research reveals that other cells can be primed by pathogens, too.